comparemela.com

Page 2 - Nexgel Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

NEXGEL, Inc (NASDAQ:NXGL) Sees Significant Increase in Short Interest

NEXGEL, Inc. (NASDAQ:NXGL – Get Free Report) saw a significant increase in short interest in February. As of February 29th, there was short interest totalling 15,400 shares, an increase of 208.0% from the February 14th total of 5,000 shares. Based on an average trading volume of 18,600 shares, the short-interest ratio is currently 0.8 days. […]

Head-To-Head Review: Sigyn Therapeutics (OTCMKTS:SIGY) versus NEXGEL (NASDAQ:NXGL)

NEXGEL (NASDAQ:NXGL – Get Free Report) and Sigyn Therapeutics (OTCMKTS:SIGY – Get Free Report) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their risk, dividends, profitability, valuation, institutional ownership, analyst recommendations and earnings. Earnings and Valuation This table compares NEXGEL and […]

Global Transdermal Drug Delivery Clinical Pipeline Research Report 2023: Stages of Development, Segments, Region and Countries, Regulatory Path and Competitive Landscape

NEXGEL, Inc (NASDAQ:NXGL) Short Interest Down 46 9% in December

NEXGEL, Inc. (NASDAQ:NXGL – Get Free Report) was the target of a large decrease in short interest in the month of December. As of December 31st, there was short interest totalling 4,300 shares, a decrease of 46.9% from the December 15th total of 8,100 shares. Approximately 0.1% of the shares of the company are short […]

NEXGEL to Report Third Quarter 2023 Financial Results on November 13th

Management will host a conference call at 4:30 P.M. ET on the same day LANGHORNE, Pa., Nov. 02, 2023 NEXGEL, Inc. , a leading provider of ultra-gentle, high-water-content hydrogel products for.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.